K.Hong

[Restoring Invisible & Abandoned Trials @RIATinitiative]

The RIAT Support Center has launched an Expressions of Concern campaign with $1000 awards available for researchers who are interested in participating! (🧵)

[Restoring Invisible & Abandoned Trials @RIATinitiative]

It is not clear when the data from Moderna's COVID-19 vaccine publication in @NEJM will become available, if ever at all? Here is their data sharing statement: (🧵)
https://t.co/eqn9Zy7Bau

[Restoring Invisible & Abandoned Trials @RIATinitiative]

and a RIAT team member said in response:"...This was a taxpayer funded trial of a global public health intervention, and I think the argument for data secrecy is a weak one..."

[JPatientRepOutcomes @JPRO_ISOQOL]

Patient-reported outcomes in breast cancer FDA drug labels and review documents https://t.co/qO5nDisMop

[Young Academy of Europe (YAE) @yacadeuro]

🔔Reminder: Join our Webinar on #Research #Integrity!

🗓️ 22 March
🕒15:00 CET
📝Registration: https://t.co/qTTDGJeQBJ

How can we support and protect early-career researchers in cases of scientific misconduct?

[Anisa Rowhani-Farid @AnisaFarid]

Excited to publish a letter in BMJ EBM on transparency of news media during the COVID-19 pandemic @KyungwanHong @RIATinitiative

COVID-19 information in news media: room for greater transparency https://t.co/9gEnZbihnZ

[K.Hong @KyungwanHong]

Reanalyzing drug trials in depression, chronic pain aims to unearth new data https://t.co/ElkiwiB8VI

[Restoring Invisible & Abandoned Trials @RIATinitiative]

Two new RIAT awards just announced: @EvanMayoWilson et al. will restore previously unreported harms of gabapentin for neuropathic pain and Pigott et al. will reanalyze the famous Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Study
https://t.co/5hS5DwdxZl